Immune effects of bevacizumab: killing two birds with one stone

about

Anti-angiogenic agents in metastatic colorectal cancer Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.

P2860

Q26801911-26C3EBA9-7867-4A00-8633-65D4B040D959 Q55349951-C9F6054D-E1F7-4484-A4F6-EE05706981F0

P2860

Immune effects of bevacizumab: killing two birds with one stone

Item

http://www.wikidata.org/entity/Q41401879

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Immune effects of bevacizumab: killing two birds with one stone

@en

type

Item

label

Immune effects of bevacizumab: killing two birds with one stone

@en

prefLabel

Immune effects of bevacizumab: killing two birds with one stone

@en

P1476

Immune effects of bevacizumab: killing two birds with one stone

@en

P2093

Bryan T Hennessy

http://www.w3.org/2001/XMLSchema#string

Shereen Rafee

http://www.w3.org/2001/XMLSchema#string

Sinead Toomey

http://www.w3.org/2001/XMLSchema#string

Yasir Y Elamin

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

Molecular mechanisms and clinical applications of angiogenesis

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Cancer immunotherapy via dendritic cells

Accessories to the crime: functions of cells recruited to the tumor microenvironment

VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue

Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.

Improved survival with bevacizumab in advanced cervical cancer

P2888

s12307-014-0160-8

P304

15-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12307-014-0160-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267042885

http://www.w3.org/2001/XMLSchema#string

P698

25326055

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

4449343

http://www.w3.org/2001/XMLSchema#string

Immune effects of bevacizumab: killing two birds with one stone

about

P2860

P2860

Immune effects of bevacizumab: killing two birds with one stone

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932